About Us
Science & Technology
Products
Alliances
News
Investors
Careers
Trubion  
 
Trubion Pharmaceuticals is a biopharmaceutical company with significant management expertise in inflammatory disease and oncology drug development. Trubion is building a portfolio of novel, proprietary, small modular immunopharmaceutical (SMIP™) product candidates.
News
  • [more]
SMIP™ Drug Design

SMIP drugs are highly-specific, single-chain polypeptides designed with optimized target binding and effector functions to overcome limitations of therapeutic antibodies and antibody alternatives.

[more]

Pipeline

Trubion has multiple SMIP drugs in pre-clinical and clinical development. The company’s lead product, TRU-015, is in Phase 2 clinical development for the treatment of rheumatoid arthritis.

[more]